Announcement under Regulation 30 (LODR)-Credit Rating
Sahajanand Medical Technologies Limited operates in Medical Equipment & Supplies within the Healthcare sector.
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Poly Medicure LimitedPOLYMEDPOLYMED | ₹16,968 Cr | ₹17,310 Cr | ₹2,134 Cr | ₹484 Cr | 23.6% | ₹318 Cr | 17.1% | 14.5% | 11% | 294 |
| Molbio Diagnostics LimitedMOLBIOMOLBIO | ₹15,190 Cr | ₹15,603 Cr | ₹1,020 Cr | ₹262 Cr | 25.7% | ₹145 Cr | 13.6% | 23.7% | 16.2% | — |
| Sahajanand Medical Technologies LimitedSMTSMT | ₹5,062 Cr | — | — | — | — | — | — | — | — | — |
| Tarsons Products LimitedTARSONSTARSONS | ₹1,730 Cr | ₹2,112 Cr | ₹441 Cr | ₹119 Cr | 27.9% | ₹11 Cr | 3.4% | 5% | 2.3% | 361 |
| Fischer Medical Ventures LimitedFISCHERFISCHER | ₹1,645 Cr | ₹1,717 Cr | ₹367 Cr | ₹50 Cr | 14% | ₹30 Cr | 10.1% | 13.6% | 8.6% | 111 |
| Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL | ₹1,129 Cr | ₹1,129 Cr | ₹294 Cr | ₹50 Cr | 15.6% | ₹32 Cr | 10.4% | 14.7% | 12.8% | 109 |
| Hemant Surgical Industries LtdHSILHSIL | ₹939 Cr | — | ₹232 Cr | ₹23 Cr | 10% | ₹18 Cr | 7.9% | — | — | — |
| Fabtech Technologies LimitedFABTECHFABTECH | ₹620 Cr | ₹663 Cr | ₹388 Cr | ₹25 Cr | 8.5% | ₹36 Cr | 9.3% | 15.5% | 12.9% | 55 |
| Prevest Denpro LtdPREVESTPREVEST | ₹502 Cr | — | ₹72 Cr | ₹25 Cr | 34.4% | ₹20 Cr | 28.5% | — | — | — |
| Nureca LimitedNURECANURECA | ₹289 Cr | ₹290 Cr | ₹174 Cr | ₹6 Cr | 0.1% | ₹5 Cr | 1.4% | 3.3% | 1.1% | 186 |
| Earkart LtdEARKARTEARKART | ₹150 Cr | ₹150 Cr | ₹54 Cr | ₹8 Cr | 15.5% | ₹5 Cr | 9.1% | 12.1% | 7.7% | 243 |
| Choksi Asia LtdCHOKSICHOKSI | ₹118 Cr | ₹120 Cr | ₹11 Cr | ₹-2 Cr | 13.8% | ₹2 Cr | 10.8% | 18.9% | 13.5% | 142 |
Documents link to external sources (exchange filings, company investor pages).
Ratios derive from annual statements, which haven't been ingested yet.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
2 schemes · 2 fund houses
| Shares | ||||||
|---|---|---|---|---|---|---|
| SMALL CAP FUND | Nippon India Mutual Fund | 14.37 L | 66.51 | 0.09% | 1.414% | — |
| Healthcare Fund | DSP Mutual Fund | 9.03 L | 41.76 | 1.12% | 0.888% | — |
| Holder (%) | Sep 2026 |
|---|---|
| 36.2% | |
| 35.1% | |
| 11.83% | |
| Government | 0% |
| 13.42% | |
| No. of shareholders | 1,15,959 |
Promoter holding up 0 percentage points since Sep 2026.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 28 Oct 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | NSE | Buy | 7,19,743 | ₹509.43 | ₹36.67 Cr |
| 28 Oct 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | NSE | Sell | 7,19,743 | ₹508.15 | ₹36.57 Cr |
| 28 Oct 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | NSE | Buy | 5,75,186 | ₹501.64 | ₹28.85 Cr |
| 28 Oct 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | NSE | Sell | 5,75,186 | ₹502.01 | ₹28.87 Cr |
| 28 Oct 2026 | JUMP TRADING FINANCIAL INDIA PRIVATE LIMITED | Bulk | NSE | Buy | 5,69,867 | ₹515.65 | ₹29.39 Cr |
| 28 Oct 2026 | JUMP TRADING FINANCIAL INDIA PRIVATE LIMITED | Bulk | NSE | Sell | 5,55,833 | ₹508.54 | ₹28.27 Cr |
| 23 Oct 2026 | INVESCO MUTUAL FUND | Bulk | NSE | Buy | 28,07,366 | ₹371.44 | ₹104.28 Cr |
| 23 Oct 2026 | INVESCO MUTUAL FUND | Bulk | NSE | Buy | 8,00,000 | ₹374.91 | ₹29.99 Cr |
| 23 Oct 2026 | GRT STRATEGIC VENTURES LLP | Bulk | NSE | Buy | 5,38,038 | ₹382.37 | ₹20.57 Cr |
| 23 Oct 2026 | GRT STRATEGIC VENTURES LLP | Bulk | NSE | Sell | 5,38,038 | ₹382.54 | ₹20.58 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Announcement under Regulation 30 (LODR)-Credit Rating
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for Consideration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th September 2026
Sahajanand Medical Technologies Ltd - 545001 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015
| Date | Category | Subject | Filing |
|---|---|---|---|
| 4 Nov 2026, 3:49 pm | Company Update Credit Rating | Announcement under Regulation 30 (LODR)-Credit Rating | |
| 27 Oct 2026, 11:00 am | Insider Trading / SAST Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 |
| 27 Oct 2026, 10:51 am | Insider Trading / SAST Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 |
| 26 Oct 2026, 6:25 pm | Company Update Analyst / Investor Meet | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 26 Oct 2026, 5:57 pm | Board Meeting | Board Meeting Intimation for Consideration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th September 2026 |
| 24 Oct 2026, 12:04 pm | Company Update General | Sahajanand Medical Technologies Ltd - 545001 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 |
| 23 Oct 2026, 6:50 pm | Company Update General | Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') |
| 23 Oct 2026, 2:48 pm | Company Update General | Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 |